Navigation Links
New Liver Tumor Treatment

A combination treatment looks like a better option for some patients with large liver tumors. The treatment includes reducing the size of the tumor //before using lasers to heat and destroy the tumor. A new study shows the combination treatment improves the overall survival of the patients.

Radiologists use a procedure called laser-induced thermotherapy (LITT) to heat tumors. The problem is the tumor cannot be too large in order to do this procedure. Doctors say this is especially true for patients with liver tumors. "We see a lot of patients with liver tumors larger than five centimeters (about the size of a golf ball) and in the past we had to refuse them. We needed a way to reduce the tumor to a size where we could perform the laser treatment," says Thomas J. Vogl, M.D., chairman of the Department of Diagnostic and Interventional Radiology at University Hospital in Frankfurt, Germany. Doctors tried a procedure called transarterial chemoembolization (TACE), which involves cutting off the blood supply and using chemotherapy to reduce tumor size.

For the study, researchers used TACE to treat 162 patients with liver tumors. Each patient underwent two to seven TACE treatments to reduce their tumor size. The size of each tumor was measured before and during treatment. Researchers report half of the patients had a successful reduction in their tumor size. In 47 patients, there was no reduction in the size and 33 patients had disease progression.

For the patients who had successful tumor shrinkage, they then underwent the LITT procedure. Researchers say the median survival of the patients who had the combination treatment was more than two years. In patients treated only with TACE, the median survival was just over a year.

Researchers say there is another benefit to this type of treatment. This treatment is local, Dr. Vogl says. "With local chemotherapy, the patients have no pain and don’t lose their hair. This treatment allows us to be very aggressive in attacking the tumor, while maintaining a good quality of life for the patient.” These procedures are also FDA accepted and researchers say they may be used for other tumors including lung, bone and lymph node tumor.
'"/>




Related medicine news :

1. Blood Cells Capable of Regenerating Liver
2. Liver donors can thrive after transplant
3. Heavy Drinking Raises Risk of Liver Cancer
4. Arthritis Drug May Cause Liver Damage
5. Liver transplant oversight urged
6. Liver key to extending life
7. Liver cancers which spread are linked to a particular gene
8. Liver diseases: The enemy with an accomplice
9. Troubled Childhood found to affect your Liver
10. Transplants Help Liver Cancer Patients
11. Steroid-Free Liver Transplants
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... , ... February 23, 2017 , ... ... of Justice jointly issued a letter to withdraw previous guidance issued ... their gender identity. The guidance issued in May 2016 by the Obama Administration ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Hamlin Dental Group ... that they are sponsoring a raffle. Throughout the month of February, patients who visit ... a gift card for a dinner for two at the Cheesecake Factory. , ...
(Date:2/23/2017)... Los Angeles, California (PRWEB) , ... February 23, ... ... for Global Sports Development will host a diverse symposium on “Doping ... School of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will ...
(Date:2/23/2017)... ... 23, 2017 , ... ERT, a global data and technology ... Research, a leading clinical development service provider, has selected ERT’s Trial Oversight suite ... in part to an array of circumstances including the use of multiple data ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017 ... company focused on the development and commercialization of ... pain, announced that it will release fourth quarter ... Thursday, March 2nd, 2017. AcelRx management will host ... Time (1:30 p.m. Pacific Time) on March 2 ...
(Date:2/23/2017)... , Feb 23, 2017 ... Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... of around 1.8% over the next decade to reach approximately $12.8 billion ... estimates and forecasts for all the given segments on global as well ...
Breaking Medicine Technology: